Literature DB >> 23941868

Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1).

Aaron Wallace1, Kim West2, Alan L Rothman3, Francis A Ennis3, Shan Lu1, Shixia Wang1.   

Abstract

In the current study, immune responses induced by Gag DNA vaccines with different designs were evaluated in Balb/C mice. The results demonstrated that the DNA vaccine with the full length wild type gag gene (Wt-Gag) mainly produced Gag antigens intracellularly and induced a higher level of cell-mediated immune (CMI) responses, as measured by IFN-gamma ELISPOT, intracellular cytokine staining (ICS), and cytotoxic T lymphocytes (CTL) assays against a dominant CD8(+) T cell epitope (AMQMLKETI). In contrast, the addition of a tissue plasminogen activator (tPA) leader sequence significantly improved overall Gag protein expression/secretion and Gag-specific antibody responses; however, Gag-specific CMI responses were decreased. The mutation of zinc-finger motif changed Gag protein expression patterns and reduced the ability to generate both CMI and antibody responses against Gag. These findings indicate that the structure and post-translational processing of antigens expressed by DNA vaccines play a critical role in eliciting optimal antibody or CMI responses.

Entities:  

Keywords:  DNA vaccine; Gag; HIV-1; antibody; cell mediated immune responses

Mesh:

Substances:

Year:  2013        PMID: 23941868      PMCID: PMC3906393          DOI: 10.4161/hv.26009

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  61 in total

1.  Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys.

Authors:  Paula M Acierno; Jörn E Schmitz; Darci A Gorgone; Yue Sun; Sampa Santra; Michael S Seaman; Michael H Newberg; John R Mascola; Gary J Nabel; Dennis Panicali; Norman L Letvin
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells.

Authors:  Harriet L Robinson; Sunita Sharma; Jun Zhao; Sunil Kannanganat; Lilin Lai; Lakshmi Chennareddi; Tianwei Yu; David C Montefiori; Rama Rao Amara; Linda S Wyatt; Bernard Moss
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

3.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

4.  Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.

Authors:  L Berthoux; C Péchoux; M Ottmann; G Morel; J L Darlix
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.

Authors:  Daria J Hazuda; Steven D Young; James P Guare; Neville J Anthony; Robert P Gomez; John S Wai; Joseph P Vacca; Larry Handt; Sherri L Motzel; Hilton J Klein; Geethanjali Dornadula; Robert M Danovich; Marc V Witmer; Keith A A Wilson; Lynda Tussey; William A Schleif; Lori S Gabryelski; Lixia Jin; Michael D Miller; Danilo R Casimiro; Emilio A Emini; John W Shiver
Journal:  Science       Date:  2004-07-08       Impact factor: 47.728

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.

Authors:  Richard A Koup; Mario Roederer; Laurie Lamoreaux; Jennifer Fischer; Laura Novik; Martha C Nason; Brenda D Larkin; Mary E Enama; Julie E Ledgerwood; Robert T Bailer; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

8.  Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC).

Authors:  N Morellet; H Déméné; V Teilleux; T Huynh-Dinh; H de Rocquigny; M C Fournié-Zaluski; B P Roques
Journal:  J Mol Biol       Date:  1998-10-23       Impact factor: 5.469

9.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

10.  Molecular determinants of HIV-1 NCp7 chaperone activity in maturation of the HIV-1 dimerization initiation site.

Authors:  Raviprasad Aduri; Katharine T Briggs; Robert J Gorelick; John P Marino
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

View more
  5 in total

1.  In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles.

Authors:  Yun Hu; Zongmin Zhao; Marion Ehrich; Kristel Fuhrman; Chenming Zhang
Journal:  Polymer (Guildf)       Date:  2015-12-02       Impact factor: 4.430

Review 2.  The influence of delivery vectors on HIV vaccine efficacy.

Authors:  Beatrice O Ondondo
Journal:  Front Microbiol       Date:  2014-08-22       Impact factor: 5.640

3.  ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.

Authors:  Naif Khalaf Alharbi; Eriko Padron-Regalado; Craig P Thompson; Alexandra Kupke; Daniel Wells; Megan A Sloan; Keith Grehan; Nigel Temperton; Teresa Lambe; George Warimwe; Stephan Becker; Adrian V S Hill; Sarah C Gilbert
Journal:  Vaccine       Date:  2017-06-01       Impact factor: 3.641

Review 4.  DNA Immunization for HIV Vaccine Development.

Authors:  Yuxin Chen; Shixia Wang; Shan Lu
Journal:  Vaccines (Basel)       Date:  2014-02-25

Review 5.  HIV DNA Vaccine: Stepwise Improvements Make a Difference.

Authors:  Barbara K Felber; Antonio Valentin; Margherita Rosati; Cristina Bergamaschi; George N Pavlakis
Journal:  Vaccines (Basel)       Date:  2014-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.